Deep vitrectomy operation. Other specified postprocedural states
Conditions
Interventions
Intervention 1: Intervention group: In the first group prophylaxis with a combination of two drugs ketamine at a dose of 0.1 mg / kg plus Metoclopramide at a dose of 0.15 mg / kg delivered by normal s
Sponsors
Esfahan University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Candidates for vitrectomy operation under general anesthesia Hospitalization of patients after surgery for at least 24 hours Patients ability to communicate with clinicians Patients with anesthesia criteria with ASA I and ASA II surgery duration less than 3 hours and more than 1 hour
Exclusion criteria
Exclusion criteria: Patients with pain syndromes Patients with a history of drug and drug addiction Any uncontrolled systemic disease Psychological and neurological diseases Any allergies to the studied drugs
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Intensity of pain. Timepoint: Upon entering the recovery, 15 minutes and 30 minutes later,Exit-recovery, then at 4, 8, 16 and 24 hours after surgery. Method of measurement: VAS scoring system.;Nausea. Timepoint: Upon entering the recovery, 15 minutes and 30 minutes later,Exit-recovery, then at 4, 8, 16 and 24 hours after surgery. Method of measurement: VAS scoring system.;Time to extubation. Timepoint: From the time of discontinuation of the anesthetic to the exit of the endotracheal tube. Method of measurement: Patient file. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDaroush Moradi Farsani
Esfahan University of Medical Sciences
Outcome results
None listed